NDLEA survey data, UNODC findings, and peer-reviewed research on drug abuse prevalence, demographics, and trends in Nigeria — the evidence behind the headlines.
Test your awareness
Knowledge is one thing — knowing where you stand is another. Take the free 20-question challenge.
🧠 Take the Challenge — FreeClaims about drug abuse in Nigeria often circulate without sources — inflated for shock value, understated for political reasons, or simply outdated. This article summarises what the available research actually shows: the methodology, the limitations, and the most defensible conclusions.
ALTDAP is built on this evidence base. Every intervention on the platform traces back to findings like these.
The National Drug Law Enforcement Agency conducted Nigeria's most comprehensive national household survey on drug use in 2018, in partnership with the United Nations Office on Drugs and Crime (UNODC). This survey covered approximately 10,000 households across all 36 states and the FCT.
Key methodological note: The survey used a household sampling approach, which typically underestimates drug use because:
The figures below should therefore be understood as lower bounds.
NDLEA publishes annual seizure statistics, arrest data, and rehabilitation centre intake figures. These are operational records, not epidemiological surveys — they capture what law enforcement encounters, not the full population of users.
Nigerian universities and the FUTO-affiliated drug awareness research programme have produced peer-reviewed analyses of drug use in specific populations (university students, secondary school students, motor parks). These studies typically use smaller samples but are more methodologically rigorous.
The 2018 NDLEA/UNODC survey found that approximately 14.4 million Nigerians had used a psychoactive substance (excluding tobacco and alcohol) in the past year. This represents roughly 14.4% of the adult population aged 15–64 — higher than the global average of 5.6% and among the highest rates on the African continent.
Updated NDLEA reporting in 2022 placed the figure at a similar level, suggesting that the trend has not reversed despite enforcement activity.
The 15–35 age group accounts for the majority of substance users in Nigeria across all survey periods. This is consistent with global patterns: substance use disorders most commonly begin during adolescence and early adulthood, when the brain's prefrontal cortex — which governs impulse control and risk assessment — is still developing.
Secondary school students (ages 12–18) represent a priority concern. The 2018 survey found that 1 in 5 students in some states had used a non-prescribed psychoactive substance in the past year.
Substance use and drug-related crime are not uniformly distributed. The Southeast and South-South geopolitical zones show elevated rates of Mkpuru Mmiri (crystal methamphetamine) use. The Northwest and Northeast show higher rates of tramadol misuse. Codeine cough syrup consumption was historically concentrated in the North, though production restrictions have shifted some demand patterns.
This does not mean any region is "safe." Urban centres across all zones show elevated prevalence compared to rural areas.
Based on NDLEA data and corroborating academic research, the most commonly misused substances in Nigeria are:
Cannabis (Indian hemp) — Most widespread. Used across demographic groups. While often dismissed as low-risk, high-potency strains available in Nigeria are associated with psychosis risk, particularly in adolescent users.
Tramadol (high-dose non-prescribed) — Explosive growth from approximately 2015 onward, coinciding with the proliferation of illicitly manufactured tablets at 200–225mg doses. Now among the most reported substances in NDLEA rehabilitation intakes.
Codeine cough syrup — Peaked around 2017–2018 (3 million bottles per day estimated in the North alone by that NDLEA report). Production restrictions reduced availability but did not eliminate the market; demand partly shifted to tramadol.
Methamphetamine (Mkpuru Mmiri) — Emerged as a major substance of concern from approximately 2019. NDLEA seizure data show substantial increases year-on-year. Southeast Nigeria is the primary affected region.
Heroin / other opioids — Smaller but documented user population, concentrated in Lagos and Port Harcourt.
Prevention research, not just prevalence data, is the foundation for ALTDAP's design.
Accurate information delivery is among the most evidence-backed prevention approaches. Studies in Nigeria and comparable contexts consistently show that young people who receive specific, accurate information about what substances do — rather than exaggerated or moralistic messaging — make different decisions.
Social norms correction is effective where drug use is normalised by peer perception. In many student environments, perceived rates of drug use are substantially higher than actual rates. Correcting this misperception reduces initiation.
Early identification and intervention — catching problem use before dependency is established — dramatically improves treatment outcomes. A person who receives support after one year of use has far better prospects than someone who has been dependent for five years.
Fear-based campaigns without factual grounding have poor outcomes in Nigerian contexts. Young people are sophisticated media consumers and recognise exaggeration. When one claim is visibly overstated, the entire message loses credibility.
Enforcement without treatment infrastructure — arrests reduce individual users' access temporarily but do not address the demand side or help users who want to stop.
Stigma-based approaches increase barriers to seeking help. Users who fear social consequences, family shame, or legal repercussions are less likely to seek treatment before dependency is severe.
Researchers and policymakers working with Nigerian drug use data should note several limitations:
Better data would produce better interventions. ALTDAP's research component is designed to generate ongoing, accessible data on knowledge, attitudes, and behaviour among Nigerian youth — contributing to this evidence base over time.
This article presents a summary. Researchers, journalists, and policymakers who want primary sources should consult:
ALTDAP is an educational platform, not a primary research institution — but the platform is grounded in this evidence base and its design reflects what the research shows about effective prevention.
The headline figure — 14.4 million Nigerians affected — represents someone's child, sibling, student, or friend. The research is not abstract.
The same research that shows the scale of the problem also shows that awareness, early intervention, and accurate information genuinely reduce harm. That is the premise this platform is built on.
→ Take the Awareness Challenge — Free, Anonymous
→ Read about the three substances most affecting Nigerian youth
